Li Jinfeng, former deputy director of the Provincial Health and Family Planning Commission, Bao Jun, second-level inspector of the Provincial Economic and Information Commission

Date：

2022-04-02

On April 1, 2022, Li Jinfeng, former deputy director of the Provincial Health and Family Planning Commission, Bao Jun, second-level inspector of the Provincial Economic and Information Commission, chairman of the Anhui Inspection Branch of the Chinese Medical Association, Xu Yuanhong, director of the Inspection Center of the Affiliated Hospital of An Medical University, and the Inspection Center of the Affiliated Hospital of the University of Science and Technology of China Wang Baolong, director, Huang Kaiquan, director of the inspection center of An Affiliated Hospital of Traditional Chinese Medicine and other industry experts came to Huibang Bio to carry out guidance work. Wang Zhongliang, chairman of Huibang Bio, warmly received the experts and his party.

Through cordial conversations, the experts learned in detail that Huibang Biotechnology is the only technological innovation R&D enterprise based in the in vitro diagnostic industry in Anhui that focuses on industrialization and self-produced key raw materials, and was selected as a new R&D institution in Anhui Province in 2022. Product categories cover monoclonal antibody raw materials required by the market, liquid phase chemiluminescence technology, molecular diagnostic precision medical technology, blood screening technology, fluorescent immunological POCT technology, rapid immunoassay technology, dry chemical rapid detection technology, tumor cell drug sensitivity test Detection technology, in vitro diagnostic automatic equipment development technology (optical sensing development technology, mechanical transmission development technology, integrated circuit control module development technology, automation control development technology, software development), etc.

Finally, the expert research team put forward suggestions for the future development of Huibang Biotechnology, and expressed the cooperation intention of industry, university and research institutes, providing strong support , and providing support services for local enterprise project research and development and industrialization.

 

 

Related News

2024-01-22

Serving the big health industry, leapfrogging development of industry, academia and research - Anhui Huibang Biotech bloomed at the Anhui Traditional Chinese Medicine Academic Annual Conference

2023-08-07

Urine and nephropathy and defense -Dialogue column of the Diabetes Branch of the Chinese Medical Association

On August 4, 2023, the Chinese Medical Association Diabetes Branch 2023 Education Management Academic Conference was grandly held at Fengda International Hotel, Hefei City, Anhui Province.

2023-06-29

Good news! Huibang Biotechnology won the second prize of Science and Technology Progress Award of the Ministry of Education!

Recently, the Ministry of Education issued a certificate for the Outstanding Achievement Award (Science and Technology) of Scientific Research in Institutions of Higher Learning. Anhui Huibang Bioengineering Co., Ltd. jointly with the Chinese Academy of Sciences and Capital Medical University declared the project: "Research and Application of Molecular Targets for Diabetes" won the second prize of Science and Technology Progress Award of the Ministry of Education.

2023-06-12

Huibang Biotech actively implements the Hangzhou Declaration and contributes to building a healthy China

On June 11, 2023, the first China Health Promotion Conference was successfully held in Hangzhou. The conference was high-level and large-scale, and many guests from the government, medical and health circles, sports circles, education circles, science and technology circles, mass media, NGO organizations and business circles attended.

2023-06-01

Good news! Huibang Biotechnology won the "Star of Creation" Cup Innovative Product Gold Award

Wisdom medicine is upright and innovative | "Star of Creation" The 8th China Experimental Medicine Conference was grandly opened on May 27 at the Primus Hotel Conference Center in Nanchang! Huibang Bio's innovative product insulin-like growth factor binding protein-1/fetal fiber Connexin (IGFBP-1/fFN) detection kit won the 2022 "Innovation Star" Cup China Excellent Innovative Product Gold Award for In Vitro Diagnostics.